Clinical Trial Update: A Study to Find the Best Dose of Fezolinetant to Treat Hot Flashes in Women Going Through Menopause [Phase 2]

View source ↗

Summary

Phase 2 dose-finding study to identify the best dose of fezolinetant for treating hot flashes in menopausal women; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hot Flashes

Drugs mentioned

• Fezolinetant (fezolinetant)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Hot Flashes | Phase 2 | Status: COMPLETED